Press release year list 2021 2020 2019 2018 2017 2016 2015
November 14, 2016
Aptinyx to Present Data for NYX-2925 in Models of Neuropathic Pain and Traumatic Brain Injury at Neuroscience 2016
Download PDF format download (opens in new window)
November 10, 2016
Aptinyx Awarded Up to $2.85 Million in NIH Grants to Research NMDA Receptor Modulation for the Treatment of Neuropathic Pain and Age-Related Cognitive Decline
Download PDF format download (opens in new window)
September 13, 2016
Aptinyx Receives FDA Fast Track Designation for Development of NYX-2925 as Treatment for Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
Download PDF format download (opens in new window)
July 13, 2016
Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925
Download PDF format download (opens in new window)
May 10, 2016
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
Download PDF format download (opens in new window)